Patricia Daggett

Director Brand And Marketing at Oxford Biomedica Solutions

Patricia Daggett has a diverse work experience spanning over several companies and roles. Patricia most recently worked at Oxford Biomedica Solutions as the Director of Brand and Marketing. Prior to that, they spent over a decade at ZOLL Medical Corporation, where they held various positions, including Associate Director of EMS Marketing and Senior Marketing Manager for the Hospital Market. In these roles, they focused on marketing non-invasive resuscitation products for the hospital marketplace, developing strategic messaging, and improving patient outcomes.

Before joining ZOLL Medical Corporation, Patricia worked at BD Biosciences as a Product Manager, where they were responsible for commercializing new products and driving growth in the biopharmaceutical, academic, government, and clinical markets.

Patricia also gained experience as a Product Manager at Millipore Corporation, focusing on commercializing new products for the biopharmaceutical and industrial food and beverage industries.

Earlier in their career, Patricia worked at Genome Therapeutics, where they held roles as a Marketing Specialist and Scientist. As a Marketing Specialist, they developed and grew sales for the Contract Sequencing Service, led marketing communication activities, and drafted corporate news releases. As a Scientist, they worked on the federally-funded Human Genome Program and was part of the team that sequenced Chromosome 10 and implemented and managed an internal custom sequencing service. Overall, Patricia Daggett has a strong background in marketing and product management in the biotech and medical industries.

Patricia Daggett earned a Bachelor of Science (BS) degree in Biology from the University of New Hampshire, graduating in 1992. Following this, they pursued a Master of Science (MS) degree in Microbiology at the same university and completed it in 1996. In 1997, they enrolled in the Bentley University - McCallum Graduate School of Business and completed a Master of Business Administration (MBA) degree with a specialization in Marketing for the Information Age in 2002.

Location

Boston, United States

Links

Previous companies


Org chart


Teams


Offices


Oxford Biomedica Solutions

Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.


Employees

51-200

Links